gynecologic oncology at asco 2022: subgroup analysis of keynote-826
Published 2 years ago • 338 plays • Length 0:46Download video MP4
Download video MP3
Similar videos
-
3:50
gynecologic oncology at asco 2022: tv pembro in first-line recurrent or metastatic cervical cancer
-
3:42
gynecologic oncology at asco 2022: athena–mono trial (rucaparib monotherapy) for ovarian cancer
-
2:44
gynecologic oncology at asco 2022: session highlights to share with your patients
-
2:26
#esmo21 highlights on pembro chemo in 1st-line metastatic cervical cancer: the keynote-826 study
-
1:11
gyn onc at asco 2022: randomized phase iii trial on trabectedin in recurrent ovarian cancer
-
3:11
gynecologic cancer studies: what to look for at asco 2022
-
9:00
gynecologic oncology at asco 2021: cervical cancer outback trial
-
1:03:45
pathologistsecho august 2022
-
31:28
gynecologic cancers: what to ask your ob/gyn | joshua g. cohen, md | uclamdchat
-
1:26:04
overview of gynecologic cancers
-
7:46
expert report on novelties in the management of gynaecological malignancies from asco 2022
-
7:18
keynote-826: pembrolizumab chemotherapy vs placebo chemotherapy for cervical cancer
-
7:57
gynecologic oncology highlights at asco20 #sgoatasco
-
1:16
keynote 826: pembrolizumab chemo in patients with advanced cervical cancer
-
52:04
gynecologic cancers | oncology today with dr neil love: special edition — key presentations on gy...
-
3:18
gynecologic oncology at esmo congress 2021: trial study in cervical cancer
-
2:26
keynote-826: pembrolizumab plus chemotherapy for patients with metastatic cervical cancer
-
28:52
gynecologic cancer education: clinical trials update
-
31:36
icaho20 - asco direct™ highlights - gynecological oncology session - dr. elise simons
-
3:46
gynecologic oncology at asco 2018: open vs mis in cervical cancer, margul
-
5:44
mis and cervical cancer | shitanshu uppal, md, mbbs